A Third Dose of an Inactivated Vaccine Dramatically Increased the Levels and Decay Times of Anti-SARS-CoV-2 Antibodies, but Disappointingly Declined Again: A Prospective, Longitudinal, Cohort Study at 18 Serial Time Points Over 368 Days

BACKGROUND: Due to anti-SARS-CoV-2 antibody decay and SARS-CoV-2 variants, vaccine booster doses are a constant concern. It was focused on whether the third dose can quickly evoke and activate immunity and produce a sufficient and durable immune protection. OBJECTIVES: To evaluate the responses and...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Xian-Ming, Xu, Qiu-Yan, Jia, Zhi-Juan, Wu, Meng-Juan, Liu, Yan-Yun, Lin, Li-Rong, Liu, Li-Li, Yang, Tian-Ci
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098946/
https://www.ncbi.nlm.nih.gov/pubmed/35572536
http://dx.doi.org/10.3389/fimmu.2022.876037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098946/
https://www.ncbi.nlm.nih.gov/pubmed/35572536
http://dx.doi.org/10.3389/fimmu.2022.876037

Ejemplares similares